Björklund, Anders Olov Hjalmar

Nome completo

Afferenza

Dipartimento di Medicina Molecolare e Traslazionale

Mostra records

Risultati 1 - 4 di 4 (tempo di esecuzione: 0.008 secondi).

2016-01-01 Faustini, G; Longhena, F; Zaltieri, M; Pizzi, M; Benfenati, F; Bjorklund, A; Missale, C; Spano, Pf; Bellucci, A

2017-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A

2017-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, Anders Olov Hjalmar; Missale, C; Spano, Pf; Bellucci, A

2018-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A.

Titolo	Data di pubblicazione	Autore(i)
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology.	1-gen-2016	Faustini, G; Longhena, F; Zaltieri, M; Pizzi, M; Benfenati, F; Bjorklund, A; Missale, C; Spano, Pf; Bellucci, A
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution	1-gen-2017	Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system	1-gen-2017	Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, Anders Olov Hjalmar; Missale, C; Spano, Pf; Bellucci, A
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model	1-gen-2018	Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A.